Conclusions
Overall 12 month survival for PC-ECMO patients was 40%, and was 33% at
36 months. For hospital survivors, 1 year survival was 66%, and was
60% at 36 months. These data support PC-ECMO as a reasonable salvage
strategy, with mid-term survival comparable to other surgically treated
diseases.